SCHEMBL20200082

SCHEMBL20200082

CCOCCN(CC)C(=O)CBr

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.38
TSHR P16473 1/20 0.38
TRPA1 O75762 1/20 0.35
LMNA P02545 1/20 0.35
CA12 O43570 2/20 0.34
CA9 Q16790 2/20 0.34
CA1 P00915 1/20 0.34
THRB P10828 1/20 0.33
BLM P54132 1/20 0.32
PMP22 Q01453 1/20 0.32
HSD17B10 Q99714 1/20 0.32
NAMPT P43490 1/20 0.32
MEN1 O00255 2/20 0.31
KMT2A Q03164 2/20 0.31
POLB P06746 1/20 0.31
MLYCD O95822 1/20 0.30
THRA P10827 1/20 0.30
CA2 P00918 1/20 0.30
MMP1 P03956 1/20 0.30
MMP2 P08253 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5063477 0.79 ALDH1A1 (0.43) ALDH1A1TSHRLMNACA12CA9
SCHEMBL318240 0.78
SCHEMBL11374052 0.78 ALDH1A1 (0.39) ALDH1A1TSHRLMNACA12CA9
SCHEMBL1039434 0.77 ALDH1A1 (0.43) ALDH1A1TRPA1LMNACA12CA9
SCHEMBL20187626 0.77 AKT1 (0.33) ALDH1A1TSHRTRPA1
SCHEMBL11449886 0.76 ALDH1A1 (0.44) ALDH1A1TSHRLMNACA12CA9
SCHEMBL13844086 0.75 CA12 (0.61) ALDH1A1TSHRLMNACA12CA9
SCHEMBL9633149 0.74 LMNA (0.48) ALDH1A1TSHRLMNAHSD17B10MEN1
SCHEMBL3222777 0.74 ALDH1A1 (0.43) ALDH1A1TSHRLMNACA12CA9
SCHEMBL5933121 0.74 ALDH1A1 (0.43) ALDH1A1TSHRLMNATHRBBLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3544964-B1 HIGH RELAXIVITY GADOLINIUM CHELATE COMPOUNDS FOR USE IN MAGNETIC RESONANCE IMAGING Bayer Pharma AG (DE) 2020-06-17 EP disclosed
WO-2018096082-A1 HIGH RELAXIVITY GADOLINIUM CHELATE COMPOUNDS FOR USE IN MAGNETIC RESONANCE IMAGING BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2018-05-31 WO disclosed